Nivolumab Improves Survival for 80% Lung Cancer Patients
Nivolumab lung cancer therapy shows an 80% five‑year survival rate in early‑stage patients, surpassing historic outcomes and offering hope for treatment.
Liver metastasis in breast cancer explained
Liver metastasis in breast cancer explained: Learn about late-stage diagnosis, symptoms, and treatment options for metastatic breast cancer.
China liver cancer cases seen reaching 264000 by 2034
China will face 264,000 liver cancer cases by 2034, representing 71% of the global burden among eight major markets. Discover the implications.
Biomarkers market set for 11{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481} growth on early detection push
The global biomarkers market growth is set to expand 11.2{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481} CAGR through 2034, fueled by early detection initiatives in cancer diagnostics.
Oil shock and petrochemical crunch hit Asia drugmakers
The pharmaceutical supply chain crisis hits Asia drugmakers as petrochemical shortages from oil disruptions threaten medicine production. Learn about the impact
Australia’s immunotherapy boom lifts PET/CT demand
Australia's immunotherapy boom drives PET/CT demand, with the market forecast to grow 5{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481} annually through 2035. Learn how cancer cases fuel growth.